A patient with minimal myeloma treatment who survived for 20 years
Alenka Djarmila Behsen1, Esten Nymoen Vandsemb2, Tobias Schmidt Slørdahl3
1Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim. alenka.d.behsen@ntnu.no.
Haematologica
|October 5, 2023
Abstract
No abstract available in PubMed .
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
345
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
345
01:21Cancer Survival Analysis
365
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
365